未登录

E

Elaine Kingwell

university college london

H指数:37

被引数:4,620

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lymphocyte count polygenicity underlies dimethyl fumarate–associated lymphopenia in multiple sclerosis

多基因性是导致多发性硬化症患者二甲基佛波酯相关淋巴细胞减少的淋巴ocyte count polygenicity underlies dimethyl fumarate–associated lymphopenia in multiple sclerosis

Multiple Sclerosis Journal

IF5

2026-08-170

PRE

Kaarina Kowalec; Ali Manouchehrinia; Elaine Kingwell; Robert Carruthers; Ruth Ann Marrie; Charity Evans; Dalia Rotstein; Annie J Kuan; Wenzhuo Luo; Daniel Luo; Brianne Desrochers; Vilija G Jokubaitis; Jeannette Lechner-Scott; Vicki E Maltby; Kira Groen; Galen EB Wright; Britt I Drögemöller; Sasha Bernatsky; Michael C Levin; Katherine Knox; Abdullah Al Maruf; Michael Zhong; Lars Alfredsson; Jan Hillert; Ingrid Kockum; Tomas Olsson; Pernilla Stridh; Klementy Shchetynsky; Kristy Dever; Julie MacIsaac; Michael S Kobor; Helen Tremlett

Exploring the relationship between polycystic ovarian syndrome, testosterone, and multiple sclerosis in women: A nationwide cohort study and genome-wide cross-trait analysis

MULTIPLE SCLEROSIS JOURNAL

IF5

2024-11-060

OAAI

Risk of Multiple Sclerosis in People Living with HIV: An International Cohort Study

ANNALS OF NEUROLOGY

IF7.7

2023-12-145

OAAI

Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION

IF7.5

2022-09-0111

OAAI

Disease-Modifying Drug Uptake and Health Service Use in the Ageing MS Population

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-01-1311

OAAI

Disease-modifying drugs for multiple sclerosis and subsequent health service use

MULTIPLE SCLEROSIS JOURNAL

IF5

2021-12-245

OAAI

Care consumption of people with multiple sclerosis: A multichannel sequence analysis in a population-based setting in British Columbia, Canada

多发性硬化症患者的护理消费: 加拿大不列颠哥伦比亚省基于人群的多通道序列分析

MULTIPLE SCLEROSIS JOURNAL

IF5

2021-05-285

OAAI

A multiple sclerosis disease progression measure based on cumulative disability

基于累积残疾的多发性硬化症疾病进展测量

MULTIPLE SCLEROSIS JOURNAL

IF5

2021-01-253

OAAI

Short-term laboratory and related safety outcomes for the multiple sclerosis oral disease-modifying therapies: an observational study

EXPERT OPINION ON DRUG SAFETY

IF3.1

2021-01-062

PREAI

Characteristics of a population-based multiple sclerosis cohort treated with disease-modifying drugs in a universal healthcare setting

EXPERT REVIEW OF NEUROTHERAPEUTICS

IF3.4

2020-12-0912

OAAI

Accurate classification of secondary progression in multiple sclerosis using a decision tree

MULTIPLE SCLEROSIS JOURNAL

IF5

2020-12-0221

OAAI

Dealing With Treatment-Confounder Feedback and Sparse Follow-up in Longitudinal Studies: Application of a Marginal Structural Model in a Multiple Sclerosis Cohort

AMERICAN JOURNAL OF EPIDEMIOLOGY

IF4.8

2020-10-303

PREAI

A systematic review of morbidities suggestive of the multiple sclerosis prodrome

EXPERT REVIEW OF NEUROTHERAPEUTICS

IF3.4

2020-05-1838

PREAI

Fatigue, sleep disorders, anaemia and pain in the multiple sclerosis prodrome

MULTIPLE SCLEROSIS JOURNAL

IF5

2020-04-0645

PREAI

Adherence to laboratory monitoring among people taking oral drugs for multiple sclerosis: A Canadian population-based study

在口服药物治疗多发性硬化症的人群中坚持实验室监测: 一项基于加拿大人群的研究

MULTIPLE SCLEROSIS JOURNAL

IF5

2020-03-065

PREAI

Multiple cause of death analysis in multiple sclerosis: A population-based study

IF8.5

2020-02-2529

OAAI

Interrogation of the Multiple Sclerosis Prodrome Using High-Dimensional Health Data

NEUROEPIDEMIOLOGY

IF4

2020-01-1513

PREAI

Informing Medication Discontinuation Decisions among Older Adults with Relapsing-Onset Multiple Sclerosis

IF3.8

2020-01-0914

OAAI

Causes that Contribute to the Excess Mortality Risk in Multiple Sclerosis: A Population-Based Study

NEUROEPIDEMIOLOGY

IF4

2019-12-1827

PREAI

Disparities in management and outcomes of myocardial infarction in multiple sclerosis: A matched cohort study

MULTIPLE SCLEROSIS JOURNAL

IF5

2019-09-1310

PREAI